Copyright
©The Author(s) 2015.
World J Gastroenterol. Dec 7, 2015; 21(45): 12857-12864
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12857
Published online Dec 7, 2015. doi: 10.3748/wjg.v21.i45.12857
CL-LCBDE(n = 20) | nSIL-CBDE(n = 20) | P value | |
Age (yr) | 51.0 ± 19.3 | 60.5 ± 17.2 | 0.068 |
Male:female | 9:11 | 9:11 | |
Body mass index (kg/m²) | 0.064 | ||
mean ± SD | 25.00 ± 3.97 | 22.55 ± 2.69 | |
median (range) | 25.10 (19.60-34.80) | 22.45 (17.16-27.69) | |
ASA classification | 0.010 | ||
1 | 3 (15) | 10 (50) | |
2 | 15 (75) | 10 (50) | |
3 | 2 (10) | 0 (0) | |
Comorbidity | 0.231 | ||
CCI = 0 | 17 (85) | 20 (100) | |
CCI ≥ 1 | 3 (15) | 0 (0) | |
Previous abdominal surgery) | 4 (20) | 4 (20) | 1.000 |
Laboratory parameters | |||
Total leukocyte count (cells/mm3) | 9117 ± 3756 | 9123 ± 2569 | 0.274 |
ALT (IL/dL) | 319 ± 267 | 215 ± 240 | 0.068 |
Total bilirubin (mg/dL) | 3.71 ± 2.24 | 2.18 ± 2.02 | 0.079 |
Alkaline phosphatase (IL/dL) | 610 ± 321 | 453 ± 342 | 0.069 |
Radiological parameters | |||
Gallbladder wall thickening (≥ 4 mm) | 4 (20) | 7 (35) | 0.480 |
Acute cholangitis | 17 (85) | 14 (70) | 0.294 |
CBD stone(s) | 1.000 | ||
Definite | 18 (90) | 19 (95) | |
Suspicious | 2 (10) | 1 (5) | |
Indication of CBDE | 0.025 | ||
Primary intervention | 7 (35) | 15 (75) | |
Secondary intervention | 13 (65) | 5 (25) | |
After ERCP failure | 7 (35) | 5 (25) | |
Remnant CBD stone(s) after ERCP | 6 (30) | 0 (0) | |
Admission route | 1.000 | ||
ER | 12 (60) | 13 (65) | |
OPD | 8 (40) | 7 (35) |
CL-LCBDE(n = 20) | nSIL-CBDE(n = 20) | P value | |
Operative time (skin to skin, min) | 0.007 | ||
mean ± SD | 192 ± 39 | 238 ± 76 | |
median (range) | 197.5 (115-245) | 215.0 (125-365) | |
Estimated blood loss (mL) | 132 ± 309 | 75 ± 161 | 0.101 |
Completion cholangiogram | 5 (25) | 0 (0) | 0.018 |
Completion choledochoscopy | 16 (80) | 20 (100) | 0.037 |
Stone clearance | 20 (100) | 20 (100) | 1.000 |
CBD stone | 0.348 | ||
Single CBD stone | 12 (60) | 9 (45) | |
Multiple CBD stones | 8 (40) | 11 (55) | |
Mean number of CBD stone extracted | 1.9 ± 1.7 | 3.0 ± 3.2 | 0.316 |
The largest diameter of CBD stone (mm) | 0.624 | ||
mean ± SD | 12.3 ± 3.8 | 14.1 ± 4.6 | |
median (range) | 14.0 (5.0-15.8) | 13.6 (7.0-20.0) | |
Open conversion | 0 | 0 | 1.000 |
Addition of another port | 0 | 0 | 1.000 |
Gallbladder pathology | 0.234 | ||
Gangrene/empyema | 1 (5) | 4 (20) | |
Acute inflammation | 3 (15) | 3 (15) | |
Chronic inflammation | 16 (80) | 13 (65) | |
Drain placed | 19 (95) | 3 (15) | < 0.001 |
Pethidine dose (mg/kg) | 92.5 ± 120.1 | 46.5 ± 63.5 | 0.010 |
Postoperative hospital stay (d) | 0.010 | ||
mean ± SD | 5.1 ± 1.7 | 3.8 ± 2.0 | |
median (range) | 5.0 (2.0-8.0) | 3.0 (2.0-9.0) | |
Postoperative complication | 0.275 | ||
Infected subhepatic collection | 1 | 0 | |
Minor bile leak | 0 | 1 | |
Subhepatic seroma | 0 | 1 |
- Citation: Kim SJ, Kim KH, An CH, Kim JS. Innovative technique of needlescopic grasper-assisted single-incision laparoscopic common bile duct exploration: A comparative study. World J Gastroenterol 2015; 21(45): 12857-12864
- URL: https://www.wjgnet.com/1007-9327/full/v21/i45/12857.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i45.12857